Apple’s low-cost moves are both surprising and particularly compelling right now at a time when most companies are being forced to raise their prices.

It felt like the world as I experience it: no clear path, but enough moments of beauty to convince me to put one foot in front of the other.

When Anne Wojcicki was considering whether she should try to save her life’s work, genetic testing pioneer 23andMe, from bankruptcy last year, many within her inner circle offered the same advice.